HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

anecortave acetate

derived from cortisone (11 OH replaced by 9-11 double bond) and retains some of the angiostatic effects of cortisone, but none of the anti-inflammatory capabilities; structure in first source
Also Known As:
4,9(11)-pregnadien-17alpha,21-diol-3,20-dione-21-acetate
Networked: 34 relevant articles (9 outcomes, 9 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Slakter, Jason S: 6 articles (09/2006 - 02/2003)
2. Anecortave Acetate Clinical Study Group: 5 articles (01/2007 - 02/2003)
3. D'Amico, Donald J: 5 articles (01/2007 - 02/2003)
4. Murray, Timothy G: 4 articles (01/2011 - 04/2006)
5. Piña, Yolanda: 3 articles (01/2011 - 12/2009)
6. Feuer, William: 3 articles (01/2011 - 04/2006)
7. Jockovich, Maria-Elena: 3 articles (06/2010 - 04/2006)
8. Goldberg, Morton F: 3 articles (01/2007 - 02/2003)
9. Jerdan, Janice A: 3 articles (01/2007 - 02/2003)
10. Zilliox, Patricia: 3 articles (01/2006 - 02/2003)

Related Diseases

1. Macular Degeneration (Age-Related Maculopathy)
2. Choroidal Neovascularization
3. Neoplasms (Cancer)
4. Retinoblastoma (Glioblastoma, Retinal)
5. Retinal Neoplasms

Related Drugs and Biologics

1. beta Subunit Luteinizing Hormone
2. Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
3. Gelatinases
4. Retinaldehyde (Retinal)
5. ranibizumab (Lucentis)
6. verteporfin (Visudyne)
7. ROP
8. Brain Natriuretic Peptide (Natrecor)
9. Carboplatin (JM8)
10. Yttrium

Related Therapies and Procedures

1. Intraocular Injections
2. Photochemotherapy (Photodynamic Therapy)
3. Light Coagulation
4. Injections
5. Aftercare (After-Treatment)